NCT05199077: An ongoing trial by Xantho Biotechnology Co., LTD
This trial is ongoing. It must report results 4 years from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05199077 |
|---|---|
| Title | A Phase IIa Study to Investigate the Efficacy and Safety Profile of GM-XANTHO in Pressure Ulcer Patients |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Sept. 1, 2026 |
| Completion date | Dec. 31, 2028 |
| Required reporting date | Dec. 31, 2029, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |